前沿论文｜CELL INTELLIGENCE

Advancements in Immune Checkpoint-Based Immunotherapy for Triple-Negative Breast Cancer.

PubMed 2026/06/12 发表Curr Issues Mol BiolQ2 · IF 4.1（JCR 2025）

CCL19-armed oncolytic adenovirus synergizes with CCR7-expressing CAR-T cells to suppress ovarian tumor growth.

PubMed 2026/06/08 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation.

PubMed 2026/01/06 发表OncoimmunologyQ1 · IF 6.2（JCR 2025）

Advanced therapies for stomach cancer.

PubMed 2025/05/30 发表J Investig MedQ2 · IF 1.9（JCR 2025）

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives.

PubMed 2025/02/08 发表Mol MedQ1 · IF 8.3（JCR 2025）

Novel immunotherapies for breast cancer: Focus on 2023 findings.

PubMed 2024/01/23 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.

PubMed 2022/06/20 发表Front OncolQ2 · IF 3.4（JCR 2025）

Oncolytic viruses for triple negative breast cancer and beyond.

PubMed 2021/09/25 发表Biomark ResQ1 · IF 14.6（JCR 2025）

前沿论文 8